Nurse Practitioner, Adult Health · Peoria, IL
NPI
1700573151
Since 2023
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
222 NE Monroe St Ste 904
Peoria, IL, 61602
Phone (309) 224-5621
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,120
93 services
Medicare patients, 2024
30
Average age 57
Drug cost, 2024
$1.6M
1,199 prescriptions
Company payments, 2025
$226
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald L Lombard was code 99213 (office e&m - established), 39 times for 25 patients. In total Ronald L Lombard billed 93 services in 14 codes, and Medicare paid $3,120.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 39 | 25 | $42.17 | $1,645 |
| 36415 Venipuncture Blood Collection | Office | 26 | 16 | $8.65 | $225 |
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 26 | 16 | $8.65 | $225 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronald L Lombard prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 125 prescriptions and refills. In total Ronald L Lombard wrote 1,199 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 125 | 125 | 23 | $555K |
| Tivicay Dolutegravir Sodium | 55 | 55 | Under 11 | $164K |
| Juluca Dolutegravir/Rilpivirine | 38 | 38 | Under 11 | $140K |
| Rosuvastatin Calcium Generic | 36 | 87 | 13 | $1,409 |
| Atorvastatin Calcium Generic | 32 | 65 | 11 | $222 |
| Dovato Dolutegravir Sodium/Lamivudine | 31 | 31 | Under 11 | $93K |
| Gabapentin Generic | 30 | 32 | Under 11 | $313 |
| Sertraline Hcl Generic | 27 | 39 | Under 11 | $189 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 26 | 28 | Under 11 | $146K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 25 | 26 | Under 11 | $648 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 25 | 25 | Under 11 | $99K |
| Descovy Emtricitabine/Tenofov Alafenam | 24 | 24 | Under 11 | $53K |
| Omeprazole Generic | 24 | 43 | Under 11 | $189 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 22 | 22 | Under 11 | $91K |
| Pantoprazole Sodium Generic | 22 | 34 | Under 11 | $182 |
Brand drugs: 458 claims; generic drugs: 741 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald L Lombard $226 ($226 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $197.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.